Document is current

Article History

Received: 24 November 2025

Accepted: 25 March 2026

First Online: 21 April 2026

Conflicts of Interest

: Dr Philip Laws received honoraria and/or grants as an investigator, speaker and/or advisory board member for AbbVie, Almirall, Actelion, Celgene, Galderma, Janssen, Lilly, Sanofi, Leo, UCB and Novartis. Mr Alberto Barea has received consultancy fees from AbbVie, Almirall, Bristol Myers Squibb, LEO Pharma, Novartis, Pfizer and UCB, Galderma; payment or honoraria for lectures, presentations, speaker bureaus, manuscript writing or educational events from Abbvie, Almirall, Bristol Myers Squibb, Eli Lilly and Company, Janssen, LEO Pharma, Novartis, Galderma, Pfizer and UCB; support for attending recent Dermatology Congress (travel, accommodation, registration) from Almirall, Lilly, Abbvie, Novartis, Janssen, Biofrontera, Sanofi and UCB; is currently a member of TORTUS beta user group but receives no shares or incentives by the company; Kingston Hospital is currently using Skin Analytics DERM as part of a trial, but he is not actively involved in the pilot. Dr Georgina Fremlin provided education, participated in advisory boards and/or received funding from the following companies: Abbvie, Galderma, Leo, Novartis, Sanofi and UCB. Dr Dominika Michno and Mr Daniel Guirguis work for the medical department at Galderma UK Ltd. Galderma UK Ltd. provided unrestricted funding for the UK survey and editorial support. Dr Kave Shams has served as investigator, consultant and advisor for AbbVie, Advanz Pharma, Almirall, Amgen, Biogen, Boehringer Ingelheim, Bristol-Myers-Squibb, Galderma, Celgene, Citryll, Eli Lilly, Incyte, Janssen, LEO Pharma, Novartis, Pfizer, Sandoz, Sanofi Genzyme, Takeda, UCB Pharma and Unilever. Charlene Murphy works for the National Eczema Society, which has received sponsorship from Galderma (UK) Ltd. for medical education and research.

: Ethical approval was not required for this study, as it involved an anonymous survey of healthcare professionals and a narrative review, and did not collect identifiable personal or patient data. This determination was confirmed using the Medical Research Council and NHS Health Research Authority research ethics decision tool. All participants provided informed consent for their anonymised data to be used for research and publication purposes, with consent implied by voluntary completion of the survey. The study was conducted in accordance with the principles of the Declaration of Helsinki (as revised in 2024).